Show simple item record

Advanced Blood-Brain Barrier Drug Delivery

dc.contributor.editorPardridge, William M.
dc.date.accessioned2023-02-02T16:44:46Z
dc.date.available2023-02-02T16:44:46Z
dc.date.issued2023
dc.identifierONIX_20230202_9783036564173_130
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/96729
dc.description.abstractAdvanced Blood-Brain Barrier Drug Delivery is a reprint with a summary editorial, followed by 16 chapters that cover five areas of brain drug delivery, including receptor-mediated transport (RMT), carrier-mediated transport (CMT), active efflux transport (AET), Trojan horse lipid nanoparticles (LNP), and in vivo methods for measurement of drug transport across the blood–brain barrier (BBB).
dc.languageEnglish
dc.subject.classificationthema EDItEUR::M Medicine and Nursingen_US
dc.subject.classificationthema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacologyen_US
dc.subject.otherblood–brain barrier (BBB)
dc.subject.otherbrain drug delivery
dc.subject.otherprodrugs
dc.subject.othersolute carriers (SLCs)
dc.subject.otherlysosomal storage disease
dc.subject.otherneuronopathic mucopolysaccharidosis
dc.subject.otherblood–brain barrier
dc.subject.otherneurodegeneration
dc.subject.otherenzyme replacement therapy
dc.subject.otherreceptor-mediated transcytosis
dc.subject.othertransferrin receptor
dc.subject.otherinsulin receptor
dc.subject.otherendothelium
dc.subject.otherreceptor-mediated transport
dc.subject.othercarrier-mediated transport
dc.subject.othergenetic engineering
dc.subject.otherIgG fusion proteins
dc.subject.othernanoparticles
dc.subject.otherliposomes
dc.subject.otherTrkB
dc.subject.otheragonist antibody
dc.subject.othervariable new antigen receptor (VNAR)
dc.subject.otherneuroprotection
dc.subject.othertransferrin receptor 1 (TfR1)
dc.subject.otherblood-brain barrier (BBB)
dc.subject.other6-OHDA
dc.subject.otherParkinson’s disease
dc.subject.otherbispecific antibody
dc.subject.otheralpha-synuclein (αSYN)
dc.subject.otherParkinson’s disease (PD)
dc.subject.otherimmunotherapy
dc.subject.othermonoclonal antibody
dc.subject.othertransferrin receptor (TfR)
dc.subject.otherreceptor-mediated transcytosis (RMT)
dc.subject.othersingle domains antibody
dc.subject.otherIGF1R
dc.subject.otherneurotensin
dc.subject.otherprotein-based therapy
dc.subject.otherlysosomal storage disorders
dc.subject.otherfusion proteins
dc.subject.otherAlzheimer’s disease
dc.subject.otherneurotrophic factors
dc.subject.otherdecoy receptors
dc.subject.otherATP-binding cassette transporters
dc.subject.otherdrug delivery
dc.subject.otherischemic stroke
dc.subject.otherSLC transporters
dc.subject.otherlipid nanoparticle
dc.subject.otherssPalm
dc.subject.othermRNA transfection
dc.subject.otherhCMEC/D3 cells
dc.subject.othercell toxicity
dc.subject.otherSWATH-MS
dc.subject.othertranslation
dc.subject.otherchaperonin-containing TCP-1
dc.subject.otherproton-coupled organic cation antiporter
dc.subject.otherphoto-affinity labeling
dc.subject.otherproteomics
dc.subject.otherSWATH-MS (sequential window acquisition of all theoretical-mass spectra)
dc.subject.otherpharmacokinetics
dc.subject.othercompartmental models
dc.subject.otherphysiologically based PK models
dc.subject.otherblood-brain barrier
dc.subject.otherantibody
dc.subject.othercavernous sinus
dc.subject.otherBBB–peptide shuttle
dc.subject.otherbrain delivery
dc.subject.othersolute carrier (SLC) transporters
dc.subject.otheramyotrophic lateral sclerosis (ALS)
dc.subject.otherNSC-34 cell lines
dc.subject.othertaurine transporter (Taut)
dc.subject.otherlarge amino acid transporter 1 (LAT1)
dc.subject.othermonocarboxylate transporters (MCTs)
dc.subject.otherorganic cation transporters (OCTNs)
dc.subject.othercholine transporter-like protein-1 (CTL1)
dc.subject.otherTNF-α inhibitor
dc.subject.othermolecular Trojan horse
dc.subject.otherendosomal
dc.subject.otherliposome
dc.subject.othernanoparticle
dc.subject.othertargeting
dc.subject.othertransferrin
dc.subject.othern/a
dc.titleAdvanced Blood-Brain Barrier Drug Delivery
dc.typebook
oapen.identifier.doi10.3390/books978-3-0365-6416-6
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0
oapen.relation.isbn9783036564173
oapen.relation.isbn9783036564166
oapen.pages496
oapen.place.publicationBasel


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/